Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 82.00
-1.00 (-1.20%)
At close: Feb 6, 2026
Ribomic Market Cap
Ribomic has a market cap or net worth of 4.45 billion as of February 6, 2026. Its market cap has increased by 25.48% in one year.
Market Cap
4.45B
Enterprise Value
1.23B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
82.00
Market Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 4.45B, a decrease of -80.61%. That is a compound annual growth rate of -13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 4.45B | 8.11% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PRISM BioLab Co.,LTD | 7.05B |
| Linical | 6.93B |
| Soiken Holdings | 6.80B |
| TMS Co., Ltd. | 6.73B |
| Noile-Immune Biotech | 6.50B |
| Kohjin Bio | 6.15B |
| Carna Biosciences | 5.65B |
| D. Western Therapeutics Institute | 5.37B |